We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
BIO-RAD LABORATORIES

Download Mobile App





Immunodiagnostic Systems Showcases Next-Gen Immunoanalyzer at AACC

By LabMedica International staff writers
Posted on 31 Jul 2018
Print article
Image: The IDS-iSYS multi-discipline automated system (Photo courtesy of Immunodiagnostic Systems).
Image: The IDS-iSYS multi-discipline automated system (Photo courtesy of Immunodiagnostic Systems).
Immunodiagnostic Systems (Tyne & Wear, UK) showcased its next generation immunoanalyzer, the IDS-i10, at the AACC annual meeting and exhibition, the world’s largest scientific conference and tradeshow in the laboratory medicine field. This year marked the 70th edition of the scientific meeting and clinical lab expo, hosted in McCormick Place, in Chicago, USA.

The exhibition provided a platform to connect with the world’s thought leaders in breaking laboratory medicine operating in fields, including clinical chemistry, molecular diagnostics, mass spectrometry, translational medicine and lab management. The tradeshow was full of technological advances as over 200 new product introductions were unveiled and demonstrated. Additionally, research developments and changes in the laboratory medicine field were discussed in a variety of clinical areas through an educational experience, which could be tailored by selecting from a range of scientific sessions.

Immunodiagnostic Systems is a provider of in-vitro diagnostic solution to the clinical laboratory market. The company develops, manufactures and markets immunoassays and automated immunoanalyzer technologies to provide improved diagnostic outcomes for patients. Its immunoassay portfolio is a combination of an endocrinology specialty-testing menu and assay panels in complementary fields.

At AACC 2018, Immunodiagnostic Systems showcased its new IDS-i10 immunoanalyzer with faster testing capability and the capacity to connect to laboratory track systems. The instrument is designed to help medical professionals perform automated immunoassays more efficiently than ever. The company also discussed its automated and manual assay panels, with its experts available at the event to assist with queries from the attendees.

Related Links:
Immunodiagnostic Systems

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The real-time multiplex PCR test is set to revolutionize early sepsis detection (Photo courtesy of Shutterstock)

1 Hour, Direct-From-Blood Multiplex PCR Test Identifies 95% of Sepsis-Causing Pathogens

Sepsis contributes to one in every three hospital deaths in the US, and globally, septic shock carries a mortality rate of 30-40%. Diagnosing sepsis early is challenging due to its non-specific symptoms... Read more

Pathology

view channel
Image: The QIAseq xHYB Mycobacterium tuberculosis Panel uses next-generation sequencing (Photo courtesy of 123RF)

New Mycobacterium Tuberculosis Panel to Support Real-Time Surveillance and Combat Antimicrobial Resistance

Tuberculosis (TB), the leading cause of death from an infectious disease globally, is a contagious bacterial infection that primarily spreads through the coughing of patients with active pulmonary TB.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.